Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-( 1,1-dioxo-1lamda6-thiomorpholin-4-yl)- 4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl] -N-methyl-isobutyramide

Details for Australian Patent Application No. 2004208483 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Hoffmann, Torsten; Waldmeier, Pius; Schwitter, Urs; Hoffmann-Emery, Fabienne; Nick, Sonia

Agent Spruson & Ferguson

Pub. Number AU-B-2004208483

PCT Pub. Number WO2004/067007

Priority 03002134.9 31.01.03 EP

Filing date 23 January 2004

Wipo publication date 12 August 2004

Acceptance publication date 6 March 2008

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/067007 Priority application(s): WO2004/067007

6 March 2008 Application Accepted

  Published as AU-B-2004208483

10 April 2008 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to remove co-inventor Hoffmann, Torsten. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

24 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208487-Use of expanded constituents and manufacture of products therefrom

2004208479-Foam dispenser